Medtronic lands CE Mark approval in the European Union for its new Engager transcatheter aortic valve implantation system.
Medical device giant Medtronic (NYSE:MDT) won European regulatory approval for its Engager transcatheter aortic valve implantation system, the company announced today.
The CE Mark indication includes approval for transapical delivery of the valve in treatment of patients with aortic stenosis who are too sick to undergo traditional surgery.
